CLINICAL ROLE -
Join Pharmacy Times® Clinical Forum Events
Engage with experts in roundtable discussions on specialized therapeutic areas. Gain real-world insights and best practices from top institutions. Learn more
Enhancing Patient Care in Heart Failure–Related Anemia Through Improved Communication, Monitoring, and Education
Pharmacists can optimize management of this condition with intravenous iron therapy guidance.
Pharmacists Play an Essential Role in Bispecific Therapy for Multiple Myeloma
Pharmacists also navigate the REMS program and monitor and manage adverse effect profiles associated with bispecifics.
Pharmacists Help Patients With HFrEF Manage and Navigate Their Iron Deficiency Therapies
Pharmacists also educate, advocate, and ensure patients with heart failure with reduced ejection fraction (HFrEF) and anemia are receiving the appropriate regimens.
Advancing Care for Metastatic Breast Cancer: Oncology Pharmacists Tackle Innovation, Biomarkers, and Operational Hurdles
New drugs and collaborative care may be key to overcoming trial closures, weak guidelines, and inefficiencies.
Strategies and Opportunities to Enhance Pharmacists’ Role in Hyperkalemia Management
Pharmacists can improve hyperkalemia management through collaboration and innovation.
Optimizing Cholesterol Management: Incorporating Injectable Lipid-Lowering Therapies
Challenges include therapy gaps, nonadherence, and fragmented care.
Navigating the Challenges of Bispecific Antibodies in Relapsed and Refractory Multiple Myeloma
Managing bispecific antibodies requires collaboration and meticulous protocols.
Pharmacists Are Key Partners in Navigating Treatment With B-Cell Therapies
Pharmacists bridge communication gaps and enhance shared decision-making.
Advancing Precision Oncology: The Role of Targeted Therapies in HR+, HER2– Breast Cancer
A panel of experts discuss treatment of HR+, HER2– breast cancer with therapies such as ribociclib, alpelisib, everolimus, and elacestrant.
Transforming CLL Management: Pharmacists' Impact on Treatment Strategies, Adherence, and Quality of Life
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Evolving Heart Failure Management: The Role of Iron Deficiency Anemia
Coming Soon
The Pharmacist’s Role on the Multiple Myeloma Care Team Can Vary Among Cancer Centers When Treating Patients With Bispecifics
Dispensing, communicating, and recording information may look different at each center.
Treatment Approaches for Patients With Graft-Vs-Host Disease May Require Flexibility
Pharmacists support treatment adherence as well as monitor adverse effects, drug-drug interactions, and quality of life.
Pharmacists Enhance Care for Patients With HR+/HER2– Breast Cancer on CDK4/6 Inhibitor Therapy
Pharmacists play a crucial role in supporting patients with HR+/HER2– breast cancer.
Navigating Bispecific Antibodies for Multiple Myeloma: Best Practices and Clinical Implementation
Patients can face barriers to BCMA-targeted treatments.
Navigating the Complexities of NSCLC Treatment: The Clinical and Economic Impact of Care
The financial burden has increased significantly since 2015.
Optimizing Cholesterol Management With Injectable Lipid-Lowering Therapies
Pharmacologic approaches can increase the use of injectables.
Adjunct Lipid Therapies Offer Options for Lowering LDL
New strategies can improve cholesterol management in patients with ASCVD.
Expanding Roles, New Approaches for Pharmacists in Managing Graft-Vs-Host Disease
When treating patients with graft-vs-host disease, pharmacists are often responsible for selecting treatment regimens while navigating other spheres of care.
Patients With CLL Present Heterogeneously
Certain patients may present asymptomatically, affecting treatment options.
Monitoring Treatment, Managing Quality of Life in Patients With ccRCC
The pharmacist’s role may vary across different practices and institutions.
Treatment of cGVHD Requires a Patient-Centered Approach
The complexity of the disease and number of treatment options can necessitate a personalized approach.
Pharmacists May See Patients With NSCLC More Often Than Other Care Team Members
This frequency can allow for faster observation of toxicities and adherence issues.
Guiding Principles in the Management of cGVHD
In addition to the current principles and treatment regimens, there are upcoming data on myelofibrosis drugs that could be reported as early as 2024.
Pharmacists Can Help Address Treatment Challenges for Patients With Cholangiocarcinoma
Treatment options can be limited for this patient population.
Medication Adherence to BTK Inhibitors Can Pose Challenges for Patients With CLL
Although treatment is effective, AEs remain difficult for patients.
Additional Guidelines Around Biomarkers Could Improve Adjuvant Treatment of Early-Stage NSCLC
The fast pace of information can make it difficult to efficiently apply data to care.
With High Medication Burden of GVHD, Pharmacists Play a Critical Role in Supporting Education, Medication Adherence
Pharmacists can improve both quality of life and financial toxicity for patients.
Advocacy, Education of Individuals With Myeloproliferative Neoplasms Are Important to Support Patient Engagement, Outcomes
Pharmacists also have the resources to help advocate for better care for patients.
Pharmacists’ Involvement in Treatment Decisions for NSCLC Has Increased and Evolved
A plethora of targeted therapies, biomarker-driven therapies, and immunotherapies are now available.